Home
overview

The conference listed on this page was held in February 2010. For information on the 2011 conference go to www.stemcells-event.com 

 

Stem Cells Conference

  

 

SMi's Stem Cells conference offers an unparalleled opportunity to learn about scientific and commercial developments in regenerative medicine.

"The presentations were excellent. It was worth taking the opportunity to hear these people talk" Senior Representative, Johnson & Johnson, Stem Cells 2009 Attendee

 

  • Supplement your existing knowledge through thought provoking presentations
  • Transfer knowledge with fellow senior executives
  • Evaluate your commercial efforts against those leading the way
  • Meet the leading figures in regenerative medicine
  • Collaborate on new projects and ideas
  • Engage with potential new clients and suppliers
  • Learn from leading experts
  • Leave with a wealth of knowledge and new contacts 

 

All those responsbile for research, business development, translational medicine, process development and alliance management, including:

  • Business Development Managers
  • Chief Executive Officers
  • CSOs
  • Directors of Commercialisation
  • Directors of Manufacturing
  • Heads of Partnering and Licensing
  • Heads of Translational Medicine
  • Medical Directors
  • Principal Scientists
  • Product Managers
  • Research Directors
  • Senior Scientists
  • Senior Vice Presidents of R&D
  • VP - Operations
 

 

Organisations represented at our inaugural Stem Cells conference included:

  • Asterand 
  • Baxter BioSurgery
  • European Patent Office
  • Federal Institute for Risk
  • Finnish Red Cross Blood Service
  • Genzyme
  • Geron
  • ITI Lifesciences
  • Johnson & Johnson
  • Kiadis Pharma
  • MHRA
  • Novartis Pharma
  • Novo Nordisk
  • Pfizer Global Research and Development
  • Roche
  • Stemgent
  • Thermo Fisher Scientific

 

 

 

 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Professor Dame Julia Polak

Professor Dame Julia Polak, , Imperial College, London

9:10 Stem Cells - Where are we now? Where are we going?

Professor Dame Julia Polak

Professor Dame Julia Polak, , Imperial College, London

  • Existing research
  • Current developments
  • The future
  • 9:30 Stem cells and the treatment of retinal degeneration

    Lyndon da Cruz

    Lyndon da Cruz, Consultant Vitreo-Retinal Surgeon, Moorfields Eye Hospital

  • What is dry AMD?
  • Growing RPE cells from embryonic stem cell lines
  • Progress of trials
  • Support from Pfizer
  • Applying for MHRA approval
  • 10:05 Stem cells and neurodegenerative conditions

    Roger Barker

    Roger Barker, Reader, Cambridge Institute for Brain Repair, University of Cambridge

  • Neural stem cell behaviour
  • Potential therapy development
  • Progress to date
  • 10:40 Morning Coffee

    11:10 Pfizer and regenerative medicine

    Paul Whiting

    Paul Whiting, Site Lead and Executive Director, Pfizer Regenerative Medicine

  • Internal and external investments
  • Platforms for regenerative medicine within a pharmaceutical company
  • Challenges of a stem cell therapy
  • 11:45 Creating bone like materials from stem cells

    Molly Stevens

    Molly Stevens, Professor of Biomedical Materials and Regenerative Medicine, Imperial College London

  • Latest research
  • Differing cell types
  • Quality of bone like material produced
  • Next steps
  • 12:20 Developing therapies for chronic liver disease

    Stuart Forbes

    Stuart Forbes, Professor of Transplantation and Regenerative Medicine, University of Edinburgh

  • Possibilities of stem cell therapy
  • Research to date
  • Liver fibrosis
  • Liver cancer
  • 12:55 Networking Lunch

    14:10 Magnetic targeting and imaging of stem cells

    Mark Lythgoe

    Mark Lythgoe, Director , Centre for Advanced Biomedical Imaging

  • Introduction to magnetic nanoparticles for imaging, targeting and hyperthermia in stem cells
  • Enhanced uptake of stem cells using magnetic targeting in vascular damage
  • High-field MRI of stem cell homing to lung metastases
  • Novel MRI contrast agents for stem cell tracking
  • MRI investigation of the therapeutic potential of Amniotic Fluid Stem cells
  • Magnetic nanoparticles as a hyperthermic therapy following stem cell delivery
     
  • 14:45 Cancer stem cells as therapeutic targets

    Malcolm Alison

    Malcolm Alison, Professor of Stem Cell Biology, Centre for Diabetes, Barts and the London School of Medicine and Dentistry

  • Normal stem cells and the origins of cancer
  • Prospective identification of cancer stem cells
  • EMT as a major force in tumour progression
  • Overcoming the radio-and chemoresistance of cancer stem cells
  • 15:20 Afternoon Tea

    15:50 Induced pluripotent stem cells - Potential and reliability

    Marc Lalande

    Marc Lalande, Professor and Chairman, University of Connecticut Health Centre

  • Assessing advances and research in iPS cells
  • hESC VS iPSC
  • Reliability of iPS cells as models of human disease
  • Benefits for drug development
     
  • 16:25 Cardiovascular disease modelling

    Sian Harding

    Sian Harding, Professor of Cardiac Pharmacology, National Heart and Lung Institute , Imperial College London

  • Stem cell based disease modelling
  • Cardiomyocyte function
  • Benefits of stem cell disease modelling
     
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Cathy Prescott

    Cathy Prescott, Director, Biolatris

    9:10 Effective clinical trials

    Tom Okarma

    Tom Okarma, Chief Executive Officer & President, Geron

  • Developing effective trials of GRNOPC1
  • Achieving Food and Drug Administration (FDA) clearance
  • Phase 1 trials
  • Procedures
  • Measuring efficacy
  • Timescales and endpoints 
  •  

    9:50 Ethical considerations of stem cell science

    Søren Holm

    Søren Holm, Professor, Centre for Social Ethics and Policy, University of Manchester

  • What are the objections?
  • Embryonic stem cells
  • Therapeutic cloning
  • iPS cells
  • Reacting to public interest
  • Education
     
  • 10:30 Morning Coffee

    11:00 Regulatory status of stem cell science

    Glyn Stacey

    Glyn Stacey, Director, UK Stem Cell Bank

  • European regulatory developments
  • Global regulatory developments
  • How do regulations impact on research and technology?
     
  • 11:40 Boosting stem cell numbers in the blood: a pharmacological approach to regenerative medicine

    Sara Rankin

    Sara Rankin, Reader in Leukocyte and Stem Cell Biology, National Heart & Lung Institute, Imperial College London

  • Stem cell trafficking in vivo
  • Stimulating mobilization of endogenous progenitor cells from the bone marrow into the blood
  • Use of Mozobil and VEGF
  • Potential treatments
  • 12:25 Networking Lunch

    13:50 Stem cells & regenerative medicine; a licensing perspective

    Huseyin  Mehmet

    Huseyin Mehmet, Director Exploratory Biomarkers, Merck Research Laboratories

  • Knowing what Merck wants
  • Processes.
  • Opportunities & utilities.
  • Thresholds, realism & limits
     
  • 14:30 Mozobil [Plerixafor] and stem cell mobilisation

    Sunil Navani

    Sunil Navani, Medical Director - Oncology & Transplantation , Genzyme

  • Stem cell mobilisation
  • CXCR4 antagonism - clinical development and future applications
     
  • 15:10 Afternoon Tea

    15:40 Developing small molecule regenerative drugs

    Yen Choo

    Yen Choo, Chief Executive Officer, Plasticell

  • Proliferation and differentiation of stem cells
  • Tissue development and repair
  • Alliances
  • Funding
     
  • 16:20 Stem cells, acquisitions and strategic alliances

    Alain Vertès

    Alain Vertès, Global Alliance Director, F.Hoffman-La Roche

  • Practicalities of alliances
  • Benefits
  • Long term plans

     

  • 17:00 Chairman’s Closing Remarks and Close of Day Two

    +

    Workshops

    Practical steps and strategies on obtaining patent protection for stem cells
    Workshop

    Practical steps and strategies on obtaining patent protection for stem cells

    Crowne Plaza Hotel - St James
    17th February 2010
    London, United Kingdom

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51
    London SW1E 6AF
    United Kingdom

    Crowne Plaza Hotel - St James

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.